c2
General Information
DCTPep ID DCTPep00440
Peptide Name c2
Sequence KWXWKK
Sequence Length 6
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
Ramos | Burkitt lymphoma; Burkitt lymphoma | IC50=1.71±0.6 μM | MTT assay | Not available | 1 |
Ramos | Burkitt lymphoma; Burkitt lymphoma | IC50=7.9±0.3 μM | MTT assay | Not available | 1 |
Hemolytic Activity Human red blood cells: EC50=31 μM
Normal (non-cancerous) Cytotoxicity MRC-5: IC50=13±1 μM
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond NCB: Lys1<--->Lys6
N-terminal Modification lactam
C-terminal Modification lactam
Other Modification X=2-Nal-CH2-
Chiral L
Physicochemical Information
Formula Not Applicable
Absent amino acids Not Applicable
Theoretical pI Not Applicable
Acidic residues Not Applicable
Basic residues Not Applicable
Polar residues Not Applicable
Molecular weight (Average) Not Applicable
Molecular weight (Monoisotopic) Not Applicable
Common amino acids Not Applicable
Net charge Not Applicable
Instability index (II) Not Applicable
Aliphatic index Not Applicable
Grand average of hydropathicity (GRAVY) Not Applicable
Half Life
Not Applicable
Extinction coefficients
Not Applicable
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22933412
Title Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid
Doi 10.1002/psc.2441
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available